06-10-2015, 10:57 PM
(This post was last modified: 06-10-2015, 11:17 PM by SunilNagpal.)
A preventive and curative vaccine for type-1 diabetes has been claimed by a team of Spanish scientists. The team belonging to Universitat Autonoma de Barcelona (Spain) has used the very familiar "Liposomes" for imitating the apoptotic beta-cells of pancreas, thereby preventing the self-destruction of the beta-cells by the body.
Earlier, the dendritic cells (immune cells) of the subjects used to be extracted and subsequently manipulated and re-injected into the subjects to avoid the destruction of the insulin-producing pancreatic cells (beta cells) in the body.
The Liposome mediated prevention of type-1 diabetes has been currently tested on mice and is all-set to be tested in Humans through clinical trials.
Following figure gives an idea of the findings in nutshell (taken from the publicly available paper at PLOS ONE):
Cumulative incidence (percentage) of T1D in NOD mice treated with PSAB-liposomes (PSAB-lipo, circles, n = 12), PS-liposomes (PS-lipo, squares, n = 18), and sham group (triangles, n = 26). Significant differences were found when compared group treated with PSAB-liposomes versus sham group (*p≤0.05, Kaplan-Meier log-rank analysis).
Full paper on this research may be referred to in PLOS ONE.
Link to paper: http://journals.plos.org/plosone/article...ne.0127057
Earlier, the dendritic cells (immune cells) of the subjects used to be extracted and subsequently manipulated and re-injected into the subjects to avoid the destruction of the insulin-producing pancreatic cells (beta cells) in the body.
The Liposome mediated prevention of type-1 diabetes has been currently tested on mice and is all-set to be tested in Humans through clinical trials.
Following figure gives an idea of the findings in nutshell (taken from the publicly available paper at PLOS ONE):
Full paper on this research may be referred to in PLOS ONE.
Link to paper: http://journals.plos.org/plosone/article...ne.0127057